A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Clinical trial NCT00532974 · UNKNOWN
Trial details
- NCT number
- NCT00532974
- Sponsor
- Epimmune
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.